Department of Military Affairs Tender by Indian Army (GEM/2025/B/6121000)

Dicyclomine HCL IP 20 mg plus Paracetamol IP 500 mg Tab,Cap Doxycycline 100 mg,Amikacin Sulphate 25

Goods
Qty:1.9L
EMD: ₹258
Department of Military Affairs Tender by Indian Army (GEM/2025/B/6121000)

Tender Timeline

Tender Issue
May 3, 2025 at 12:20 PM

Tender Title: Gem 2025 Bid for Pharmaceutical Supplies
Reference Number: GEM/2025/B/6121000
Issuing Authority/Department: Department of Military Affairs, Ministry of Defence

The scope of work for this tender includes the supply of a range of pharmaceutical products, specifically Dicyclomine HCL IP 20 mg plus Paracetamol IP 500 mg Tablets and Cap Doxycycline 100 mg. The total quantity required is 185,696 units, aimed at fulfilling the health and medical needs of personnel under the Department of Military Affairs. The main objective is to ensure timely delivery and high-quality pharmaceuticals to support military operations.

Eligibility Criteria: To qualify for this tender, bidders must be registered entities with a proven track record in supplying pharmaceutical products. A valid registration with relevant health authorities and compliance with industry standards is mandatory.

Technical Requirements: Bidders must meet strict technical specifications, including adherence to quality standards set forth by health regulatory authorities. This includes documentation of manufacturing practices, proof of procurement from certified suppliers, and quality assurance measures that guarantee the efficacy and safety of the products supplied.

Financial Requirements: Bidders must demonstrate financial stability, including the ability to self-finance or provide performance guarantees. Adequate financial resources should be evident through submitted financial statements for the previous fiscal years.

Document Submission Details: Interested bidders are required to submit their documentation electronically, as specified in the tender guidelines. All documents must be provided in acceptable formats to ensure smooth evaluation processes.

Special Provisions: This tender encourages participation from Micro, Small, and Medium Enterprises (MSEs) with additional benefits to support their involvement in government procurements. Startups are also invited to participate, ensuring they meet the laid-out eligibility criteria.

Evaluation Process: The evaluation will be based on a thorough review of submitted documents, technical compliance, financial analysis, and overall bid pricing. The tender evaluation committee will assess each bid based on quality standards, delivery timelines, and cost-effectiveness.

Delivery Locations: Successful bidders will be required to deliver the pharmaceutical products to designated military health facilities and depots specified by the Department of Military Affairs.

Contact Information: Direct any inquiries related to this tender to the issuing authority for further guidance. However, please ensure that you do not include any personal or sensitive information in your inquiries.

This tender emphasizes the importance of quality and compliance, seeking suppliers who can deliver pharmaceutical products that meet stringent regulatory standards. All bidders are encouraged to thoroughly review the requirements and prepare their submissions accordingly to ensure a successful application.


Tender BOQ Items

16 Items
1.

Dicyclomine HCL IP 20 mg plus Paracetamol IP 500 mg Tab

Dicyclomine HCL IP 20 mg + Paracetamol IP 500 mg Tab

Qty:3900
Unit:no
30
2.

Cap Doxycycline 100 mg

Qty:26900
Unit:no
30
3.

Amikacin Sulphate 250 mg slace 2 ml Inj

Amikacin Sulphate 250 mg/2 ml Inj

Qty:8400
Unit:vial
30
4.

Etophylline BP 84 point 7 mg and Theophylline IP 25 point 3, per ml, 2 ml Inj

Etophylline BP 84.7 mg and Theophylline IP 25.3, per ml, 2 ml Inj

Qty:540
Unit:amp
30
5.

Gentamycin sulphate Inj IM slace IV 40mg slace ml, 2 ml Inj

Gentamycin sulphate Inj IM/IV 40mg/ml, 2 ml Inj

Qty:1800
Unit:amp
30
6.

Metronidazole Inj for IV use containing 500 mg per bott of 100 ml

Qty:8000
Unit:bott
30
7.

Vitamin B complex with a minimum concentration of vit B1 5mg, Vit B6 3mg and amp Vit B12 5mcg therapeutic Tab slace Cap

Vitamin B complex with a minimum concentration of vit B1-5mg, Vit B6-3mg and amp Vit B12-5mcg therapeutic Tab/Cap

Qty:104775
Unit:no
30
8.

Aceclofenac 100 mg, Paracetamol 500 mg Tab

Qty:4800
Unit:no
30
9.

Cephalexin IP 250mg Cap

Qty:5400
Unit:no
30
10.

Ciprofloxacin 200 mg slace 100ml Inj

Ciprofloxacin 200 mg/100ml Inj

Qty:1700
Unit:bott
30
11.

Diclofenac 25 mg slace ml IP, 3ml Inj

Diclofenac 25 mg/ml IP, 3ml Inj

Qty:2660
Unit:amp slace vial
30
12.

Levofloxacin IP 250 mg Tab

Qty:3900
Unit:no
30
13.

Povidone Iodine 10 percent solution, bott of 100 ml

Povidone Iodine 10% solution, bott of 100 ml

Qty:2700
Unit:bott
30
14.

Povidone Iodine solution 5 percent bottle of 100 m

Povidone Iodine solution 5% bottle of 100 m

Qty:5400
Unit:bott
30
15.

Tab Roxithromycin 150 mg

Qty:1080
Unit:no
30
16.

Inj Ranitidine HCl 50 mg, 2 ml

Qty:3741
Unit:amp
30

General Information

Item Category
Dicyclomine HCL IP 20 mg plus Paracetamol IP 500 mg Tab , Cap Doxycycline 100 mg , Amikacin Sulphate 250 mg slace 2 ml Inj , Etophylline BP 84 point 7 mg and Theophylline IP 25 point 3, per ml, 2 ml Inj , Gentamycin sulphate Inj IM slace IV 40mg slace ml, 2 ml Inj , Metronidazole Inj for IV use containing 500 mg per bott of 100 ml , Vitamin B complex with a minimum concentration of vit B1 5mg, Vit B6 3mg and amp Vit B12 5mcg therapeutic Tab slace Cap , Aceclofenac 100 mg, Paracetamol 500 mg Tab , Cephalexin IP 250mg Cap , Ciprofloxacin 200 mg slace 100ml Inj , Diclofenac 25 mg slace ml IP, 3ml Inj , Levofloxacin IP 250 mg Tab , Povidone Iodine 10 percent solution, bott of 100 ml , Povidone Iodine solution 5 percent bottle of 100 m , Tab Roxithromycin 150 mg , Inj Ranitidine HCl 50 mg, 2 ml
Ministry Name
Organisation Name

Financial Information

EMD Amount
₹258.00
Bid Offer Validity
180 (Days)
Arbitration Clause
No
Mediation Clause
No

Evaluation and Technical Information

Evaluation Method
Item wise evaluation/
Inspection Required
Yes

Tender Documents

5 Documents
GeM-Bidding-7718683.pdfMain Document
BOQ DocumentBOQ BOQ
BOQ DocumentBOQ BOQ
Buyer uploaded ATC documentATC ATC
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Similar Tenders

View All

Frequently Asked Questions

The eligibility requirements include being a registered entity in the pharmaceutical sector, possessing necessary licenses and certifications to manufacture or supply the specified drugs. Additionally, bidders must demonstrate experience with similar contracts and have a good track record in compliance with health regulations. It’s essential for bidders to clearly outline their qualifications in the submitted documentation to ensure they meet the criteria.

Bidders must adhere to strict technical specifications which include compliance with quality standards laid out by regulatory authorities. This involves demonstrating the ability to ensure high-quality manufacturing practices, producing documentation such as quality assurance certificates, and detailed testing reports that verify the efficacy and safety of the products supplied. All technical documents must align with the specifications outlined in the tender.

Yes, bidders are required to submit an Earnest Money Deposit (EMD) as part of the financial security requirement. This deposit ensures that the bidders are serious and committed to the tender process. The EMD typically needs to be submitted alongside the bid documents, and successful bidders will also be asked for performance security upon contract award to guarantee compliance and fulfill contract terms.

The submission of documents will be evaluated based on a clear set of criteria. This includes assessment of quality standards, compliance with technical specifications, and overall price evaluation considerations. The evaluation committee will analyze the completeness and accuracy of submitted documents, ensuring that each bid aligns with the tender requirements before making a final decision.

The tender includes specific provisions for MSEs, aimed at encouraging their participation in government procurement processes. These provide benefits such as relaxed bidding criteria, supported application processes, and possibly preference in bid evaluations. Startups are also encouraged to participate, aligning with government initiatives to promote local enterprises under ‘Make in India’ policies.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders